Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Kalundborg Bioenergi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3%   Bankruptcy risk   0.7% 3.6% 2.0% 2.0% 0.4% 1.1% 19.0% 14.9%   Credit score (0-100)   96 53 69 67 100 83 7 14   Credit rating   AA BBB A A AAA A B BB   Credit limit (kDKK)   5,174.4 0.0 16.3 20.2 17,829.3 1,906.9 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   14,397 20,511 37,005 66,473 55,011 13,348 0.0 0.0   EBITDA   14,397 979 11,295 39,308 51,446 9,773 0.0 0.0   EBIT   3,018 979 11,295 39,308 38,906 -3,016 0.0 0.0   Pre-tax profit (PTP)   -1,321.6 -2,319.0 7,423.0 28,917.0 40,974.1 -3,638.3 0.0 0.0   Net earnings   -1,029.8 -2,319.0 7,423.0 28,917.0 32,602.2 -5,590.7 0.0 0.0   Pre-tax profit without non-rec. items   -1,322 979 11,295 39,308 40,974 -3,638 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   198,546 0.0 0.0 0.0 180,854 173,189 0.0 0.0   Shareholders equity total   51,388 107,799 115,223 144,139 148,742 43,151 -16,080 -16,080   Interest-bearing liabilities   166,197 0.0 0.0 0.0 119,589 168,542 16,080 16,080   Balance sheet total (assets)   223,947 216,434 262,827 282,131 315,335 258,494 0.0 0.0   Net Debt   166,197 0.0 0.0 0.0 116,036 168,537 16,080 16,080     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   14,397 20,511 37,005 66,473 55,011 13,348 0.0 0.0   Gross profit growth   0.0% 42.5% 80.4% 79.6% -17.2% -75.7% -100.0% 0.0%   Employees   0 0 0 0 5 6 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   223,947 216,434 262,827 282,131 315,335 258,494 0 0   Balance sheet change%   45.3% -3.4% 21.4% 7.3% 11.8% -18.0% -100.0% 0.0%   Added value   14,397.2 979.0 11,295.0 39,308.0 38,906.4 9,773.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   38,797 -198,546 0 0 168,314 -20,455 -173,189 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.0% 4.8% 30.5% 59.1% 70.7% -22.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.6% 0.4% 4.7% 14.4% 14.2% 1.5% 0.0% 0.0%   ROI %   1.6% 0.4% 4.7% 14.4% 15.1% 1.7% 0.0% 0.0%   ROE %   -2.0% -2.9% 6.7% 22.3% 22.3% -5.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   22.9% 100.0% 100.0% 100.0% 47.2% 16.7% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,154.4% 0.0% 0.0% 0.0% 225.5% 1,724.4% 0.0% 0.0%   Gearing %   323.4% 0.0% 0.0% 0.0% 80.4% 390.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.3% 0.0% 0.0% 0.0% 2.3% 5.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.0 0.0 0.0 1.3 1.6 0.0 0.0   Current Ratio   0.8 0.0 0.0 0.0 1.3 1.6 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 3,552.7 4.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -6,226.6 0.0 0.0 0.0 33,542.8 32,406.8 -8,039.9 -8,039.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 7,781 1,629 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 10,289 1,629 0 0   EBIT / employee   0 0 0 0 7,781 -503 0 0   Net earnings / employee   0 0 0 0 6,520 -932 0 0